Department of Diagnostic and Interventional Radiology, University Medical Center, Mainz; Langenbeckstraße 1, 55131, Mainz, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Rhine Main, Mainz, Langenbeckstraße 1, 55131, Mainz, Germany.
Eur Radiol Exp. 2021 Mar 25;5(1):14. doi: 10.1186/s41747-021-00208-2.
Ischemic heart disease and its sequelae are one of the major contributors to morbidity and mortality worldwide. Over the last decades, technological developments have strengthened the role of noninvasive imaging for detection, risk stratification, and management of patients with ischemic heart disease. Cardiac magnetic resonance (CMR) imaging incorporates both functional and morphological characterization of the heart to determine presence, acuteness, and severity of ischemic heart disease by evaluating myocardial wall motion and function, the presence and extent of myocardial edema, ischemia, and scarring. Currently established clinical protocols have already demonstrated their diagnostic and prognostic value. Nevertheless, there are emerging imaging technologies that provide additional information based on advanced quantification of imaging biomarkers and improved diagnostic accuracy, therefore potentially allowing reduction or avoidance of contrast and/or stressor agents. The aim of this review is to summarize the current state of the art of CMR imaging for ischemic heart disease and to provide insights into promising future developments.
缺血性心脏病及其后遗症是全球发病率和死亡率的主要原因之一。在过去的几十年中，技术的发展增强了无创成像在检测、风险分层和缺血性心脏病患者管理方面的作用。心脏磁共振（CMR）成像结合了心脏的功能和形态特征，通过评估心肌壁运动和功能、心肌水肿、缺血和瘢痕的存在和程度，来确定缺血性心脏病的存在、急性和严重程度。目前已建立的临床方案已经证明了其诊断和预后价值。然而，新兴的成像技术基于对成像生物标志物的高级定量和提高的诊断准确性提供了额外的信息，因此有可能减少或避免使用对比剂和/或应激剂。本综述的目的是总结 CMR 成像在缺血性心脏病中的最新技术，并探讨有前途的未来发展方向。
